Emmanuelle Trombe, Anthony Paronneau, Kamal Naffi and Mathilde Peschard of McDermott’s Paris office represented Acticor Biotech, a biotechnology company dedicated to the development of an emergency treatment for strokes, in securing a €590,000 capital increase from investors in the crowdfunding platform Anaxago and Business Angels. The company will use the funds for product development. Read the full article
We use cookies to improve the functionality and performance of this site. By continuing to use this site, you are providing us with your consent to our use of cookies. Please see our Privacy Policy for details.